Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Combining Dextran 40 with Ringer's Lactate for treating Acute Pancreatitis

Official title: A Randomized Controlled Trial Evaluating Fluid Resuscitation in Acute Pancreatitis: Dextran 40 and Ringer's Lactate (1:3 Ratio) Versus Ringer's Lactate Alone

Run by Satu Mare County Emergency Hospital · NCT06835023 · Data updated 2026-11-12

This study is testing if combining Dextran 40 with Ringer's lactate can help people with mild to moderate acute pancreatitis recover better and avoid serious complications compared to using Ringer's lactate alone.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorSatu Mare County Emergency Hospital
Government
Locations1 site (Satu Mare, Satu Mare County)
StatusRecruiting
StartedJanuary 10, 2022
Main results expectedMay 12, 2025
Study endsMay 12, 2025
Registry record updatedFebruary 20, 2025
Trial IDNCT06835023 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with mild or moderate acute pancreatitis.

Probably not a fit

Patients with severe acute pancreatitis or those who cannot provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates whether a combination of Dextran 40 and Ringer's lactate solution can enhance fluid resuscitation in patients with mild to moderate acute pancreatitis. The study aims to determine if this combination improves patient outcomes by reducing inflammation, organ failure, and the need for intensive care unit admission compared to Ringer's lactate alone. Participants will be randomly assigned to receive either the combination treatment or Ringer's lactate alone, with regular monitoring of their condition and blood tests to assess inflammation and organ function. The goal is to identify the most effective fluid resuscitation strategy for this condition.

Why it matters

Potential benefit: If successful, this approach could lead to improved recovery and reduced complications for patients with acute pancreatitis.

How similar studies have gone: While fluid resuscitation is a critical aspect of managing acute pancreatitis, this specific combination approach is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adults (≥18 years) diagnosed with mild or moderate acute pancreatitis
* must provide written informed consent for study participation.

Exclusion Criteria:

* patients who decline to provide informed consent.
* patients are non-compliant with treatment and follow-up visits.
* pregnant individuals.
* patients requiring concomitant treatment that is contraindicated within the study protocol.
* patients who develop conditions that contraindicate the administration of the investigational medication.
* patients experiencing severe adverse reactions necessitating treatment discontinuation.

Where it's running

  • Spitalul Judetean de Urgenta Satu Mare
    Satu Mare, Satu Mare County, Romania
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.